New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF
LRND
4 hedge funds and large institutions have $5.98M invested in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 2 → 4 (+2)
25% more capital invested
Capital invested by funds: $4.77M → $5.98M (+$1.21M)
3.23% less ownership
Funds ownership: 95% → 91.77% (-3.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
GTS Securities
Miami,
Florida
|
+$553K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$105 |
Top Sellers
LRND Hedge Fund Activity: Q4 2023 in Review
4 of the 6,871 institutional investors tracked by Wall St. Rank reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) for Q4 2023, worth a combined $5.98M — up 25% from $4.77M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new LRND positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was GTS Securities, opening a new position worth an estimated $553K.
- 4 institutional investors held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) as of Q4 2023, up from 2 in Q3 2023.
- Funds reported $5.98M of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF stock for Q4 2023, up 25% quarter-over-quarter.
- 2 funds opened new New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF positions in Q4 2023 and 0 closed out, a net change of +2 holders.
- The largest New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF buyer in Q4 2023 was GTS Securities, an estimated $553K added.
Based on aggregated 13F filings for Q4 2023.